CombiMatrix Corp. (NASDAQ: CBMX) provides molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. The company specializes in prenatal diagnostics, miscarriage analysis /recurrent pregnancy loss, pediatric genetics and pre-implantation genetic screening, offering DNA-based testing … Continue reading →

Provision Interactive Technologies, Inc., a subsidiary of Provision Holding, Inc. (OTC: PVHO), is the leading purveyor of intelligent interactive 3D holographic display technologies, software and integrated solutions for both commercial and consumer-focused applications. Provision’s 3D holographic display systems represent a … Continue reading →

Midwest Energy Emissions (OTC: MEEC) delivers patented and proprietary solutions to the global coal-power industry to remove mercury from power plant emissions. The EPA requires that all U.S.-based coal- and oil-fired power plants, larger than 25 mega-watts, must remove roughly … Continue reading →

NanoViricides (NYSE: NNVC) is a pre-clinical biotech company that has utilized its patented platform technology to rapidly create anti-viral drug candidates. The company has conducted tests on more than 6,000 animals infected with various strains of influenza, HIV, dengue/dengue hemorrhagic … Continue reading →

PharmaCyte Biotech (NASDAQ: PMBC) is a clinical stage biotechnology company that develops treatments for cancer and diabetes using a proprietary cellulose based live cell encapsulation known as “Cell-in-a-Box®.” PharmaCyte cancer treatment encapsulates genetically modified live cells, which can convert an … Continue reading →

Biostage (NASDAQ: BSTG) is a biotech company in the emerging field of regenerative medicine. The company’s goal is to regenerate and restore organ function of the esophagus, trachea or bronchus damaged by cancer, trauma, infection or congenital diseases. Using its Cellframe … Continue reading →

Provectus Biopharmaceuticals (OTC: PVCT) specializes in developing oncology and dermatology therapies. Its novel investigational drug for cancer, PV-10, is designed for injection into solid tumors, thereby reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer … Continue reading →

Endonovo Therapeutics (OTC: ENDV) is a biotech company developing a bioelectronic approach to regenerative medicine. The company’s Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating and preventing vital organ failure through the reduction of inflammation and the promotion … Continue reading →

Global Self Storage, Inc. (NASDAQ: SELF) is a self-administered, self-managed real estate investment trust (“REIT”) focused on the ownership, operation, acquisition, development and redevelopment of self storage facilities in the United States. The company currently owns and operates, through its … Continue reading →